Modification  ||| S:0 E:13 ||| NNP
and  ||| S:13 E:17 ||| CC
implementation  ||| S:17 E:32 ||| NN
of  ||| S:32 E:35 ||| IN
NCCN  ||| S:35 E:40 ||| NNP
guidelines  ||| S:40 E:51 ||| NNS
on  ||| S:51 E:54 ||| IN
colon  ||| S:54 E:60 ||| NN
cancer  ||| S:60 E:67 ||| NN
in  ||| S:67 E:70 ||| IN
the  ||| S:70 E:74 ||| DT
Middle  ||| S:74 E:81 ||| NNP
East  ||| S:81 E:86 ||| NNP
and  ||| S:86 E:90 ||| CC
North  ||| S:90 E:96 ||| NNP
Africa  ||| S:96 E:103 ||| NNP
region  ||| S:103 E:110 ||| NN
Colorectal  ||| S:110 E:121 ||| NNP
cancer  ||| S:121 E:128 ||| NN
is  ||| S:128 E:131 ||| VBZ
less  ||| S:131 E:136 ||| RBR
common  ||| S:136 E:143 ||| JJ
in  ||| S:143 E:146 ||| IN
the  ||| S:146 E:150 ||| DT
Middle  ||| S:150 E:157 ||| NNP
East  ||| S:157 E:162 ||| NNP
and  ||| S:162 E:166 ||| CC
South  ||| S:166 E:172 ||| NNP
Asia  ||| S:172 E:177 ||| NNP
than  ||| S:177 E:182 ||| IN
in  ||| S:182 E:185 ||| IN
western  ||| S:185 E:193 ||| JJ
countries ||| S:193 E:202 ||| NNS
,  ||| S:202 E:204 ||| ,
with  ||| S:204 E:209 ||| IN
the  ||| S:209 E:213 ||| DT
rectum  ||| S:213 E:220 ||| NN
the  ||| S:220 E:224 ||| DT
most  ||| S:224 E:229 ||| RBS
common  ||| S:229 E:236 ||| JJ
primary  ||| S:236 E:244 ||| JJ
site ||| S:244 E:248 ||| NN
,  ||| S:248 E:250 ||| ,
unlike  ||| S:250 E:257 ||| IN
in  ||| S:257 E:260 ||| IN
the  ||| S:260 E:264 ||| DT
United  ||| S:264 E:271 ||| NNP
States ||| S:271 E:277 ||| NNPS
.  ||| S:277 E:279 ||| .
A  ||| S:279 E:281 ||| DT
project  ||| S:281 E:289 ||| NN
was  ||| S:289 E:293 ||| VBD
planned  ||| S:293 E:301 ||| VBN
to  ||| S:301 E:304 ||| TO
address  ||| S:304 E:312 ||| VB
various  ||| S:312 E:320 ||| JJ
local  ||| S:320 E:326 ||| JJ
issues  ||| S:326 E:333 ||| NNS
regarding  ||| S:333 E:343 ||| VBG
the  ||| S:343 E:347 ||| DT
management  ||| S:347 E:358 ||| NN
of  ||| S:358 E:361 ||| IN
common  ||| S:361 E:368 ||| JJ
cancers ||| S:368 E:375 ||| NNS
,  ||| S:375 E:377 ||| ,
including  ||| S:377 E:387 ||| VBG
colorectal  ||| S:387 E:398 ||| JJ
cancer ||| S:398 E:404 ||| NN
,  ||| S:404 E:406 ||| ,
and  ||| S:406 E:410 ||| CC
to  ||| S:410 E:413 ||| TO
adapt  ||| S:413 E:419 ||| VB
the  ||| S:419 E:423 ||| DT
NCCN  ||| S:423 E:428 ||| NNP
Clinical  ||| S:428 E:437 ||| NNP
Practice  ||| S:437 E:446 ||| NNP
Guidelines  ||| S:446 E:457 ||| NNP
in  ||| S:457 E:460 ||| IN
Oncology  ||| S:460 E:469 ||| NNP
( ||| S:469 E:470 ||| -LRB-
NCCN  ||| S:470 E:475 ||| NNP
Guidelines ||| S:475 E:485 ||| NNP
)  ||| S:485 E:487 ||| -RRB-
to  ||| S:487 E:490 ||| TO
the  ||| S:490 E:494 ||| DT
Middle  ||| S:494 E:501 ||| NNP
East  ||| S:501 E:506 ||| NNP
and  ||| S:506 E:510 ||| CC
North  ||| S:510 E:516 ||| NNP
Africa  ||| S:516 E:523 ||| NNP
( ||| S:523 E:524 ||| -LRB-
MENA ||| S:524 E:528 ||| NNP
)  ||| S:528 E:530 ||| -RRB-
region ||| S:530 E:536 ||| NN
.  ||| S:536 E:538 ||| .
A  ||| S:538 E:540 ||| DT
survey  ||| S:540 E:547 ||| NN
of  ||| S:547 E:550 ||| IN
oncologists  ||| S:550 E:562 ||| NN
in  ||| S:562 E:565 ||| IN
this  ||| S:565 E:570 ||| DT
geographic  ||| S:570 E:581 ||| JJ
area  ||| S:581 E:586 ||| NN
showed  ||| S:586 E:593 ||| VBD
that  ||| S:593 E:598 ||| IN
the  ||| S:598 E:602 ||| DT
management  ||| S:602 E:613 ||| NN
practices  ||| S:613 E:623 ||| NNS
and  ||| S:623 E:627 ||| CC
issues  ||| S:627 E:634 ||| NNS
regarding  ||| S:634 E:644 ||| VBG
colorectal  ||| S:644 E:655 ||| JJ
cancer  ||| S:655 E:662 ||| NN
are  ||| S:662 E:666 ||| VBP
similar  ||| S:666 E:674 ||| JJ
to  ||| S:674 E:677 ||| TO
those  ||| S:677 E:683 ||| DT
presented  ||| S:683 E:693 ||| VBN
in  ||| S:693 E:696 ||| IN
the  ||| S:696 E:700 ||| DT
NCCN  ||| S:700 E:705 ||| NNP
Colorectal  ||| S:705 E:716 ||| NNP
Cancer  ||| S:716 E:723 ||| NNP
Guidelines ||| S:723 E:733 ||| NNP
.  ||| S:733 E:735 ||| .
However ||| S:735 E:742 ||| RB
,  ||| S:742 E:744 ||| ,
2  ||| S:744 E:746 ||| CD
major  ||| S:746 E:752 ||| JJ
differences  ||| S:752 E:764 ||| NNS
exist ||| S:764 E:769 ||| VBP
:  ||| S:769 E:771 ||| :
most  ||| S:771 E:776 ||| RBS
oncologists  ||| S:776 E:788 ||| JJ
in  ||| S:788 E:791 ||| IN
the  ||| S:791 E:795 ||| DT
MENA  ||| S:795 E:800 ||| NNP
region  ||| S:800 E:807 ||| NN
prefer  ||| S:807 E:814 ||| VBP
chest  ||| S:814 E:820 ||| JJ
radiograph  ||| S:820 E:831 ||| NN
over  ||| S:831 E:836 ||| IN
CT  ||| S:836 E:839 ||| NNP
in  ||| S:839 E:842 ||| IN
pretreatment  ||| S:842 E:855 ||| JJ
workup ||| S:855 E:861 ||| NN
,  ||| S:861 E:863 ||| ,
and  ||| S:863 E:867 ||| CC
almost  ||| S:867 E:874 ||| RB
50 ||| S:874 E:876 ||| CD
%  ||| S:876 E:878 ||| NN
of  ||| S:878 E:881 ||| IN
them  ||| S:881 E:886 ||| PRP
prefer  ||| S:886 E:893 ||| VBP
to  ||| S:893 E:896 ||| TO
use  ||| S:896 E:900 ||| VB
cetuximab  ||| S:900 E:910 ||| VBN
in  ||| S:910 E:913 ||| IN
the  ||| S:913 E:917 ||| DT
first-line  ||| S:917 E:928 ||| JJ
treatment  ||| S:928 E:938 ||| NN
of  ||| S:938 E:941 ||| IN
patients  ||| S:941 E:950 ||| NNS
with  ||| S:950 E:955 ||| IN
the  ||| S:955 E:959 ||| DT
wild-type  ||| S:959 E:969 ||| JJ
KRAS  ||| S:969 E:974 ||| NNP
gene ||| S:974 E:978 ||| NN
.  ||| S:978 E:980 ||| .
The  ||| S:980 E:984 ||| DT
committee ||| S:984 E:993 ||| NN
,  ||| S:993 E:995 ||| ,
comprising  ||| S:995 E:1006 ||| VBG
9  ||| S:1006 E:1008 ||| CD
oncologists  ||| S:1008 E:1020 ||| NN
from  ||| S:1020 E:1025 ||| IN
different  ||| S:1025 E:1035 ||| JJ
countries ||| S:1035 E:1044 ||| NNS
,  ||| S:1044 E:1046 ||| ,
proposed  ||| S:1046 E:1055 ||| VBD
4  ||| S:1055 E:1057 ||| CD
modifications  ||| S:1057 E:1071 ||| NNS
to  ||| S:1071 E:1074 ||| TO
the  ||| S:1074 E:1078 ||| DT
2009  ||| S:1078 E:1083 ||| CD
version  ||| S:1083 E:1091 ||| NN
of  ||| S:1091 E:1094 ||| IN
the  ||| S:1094 E:1098 ||| DT
NCCN  ||| S:1098 E:1103 ||| NNP
Colorectal  ||| S:1103 E:1114 ||| NNP
Cancer  ||| S:1114 E:1121 ||| NNP
Guidelines  ||| S:1121 E:1132 ||| NNP
for  ||| S:1132 E:1136 ||| IN
use  ||| S:1136 E:1140 ||| NN
in  ||| S:1140 E:1143 ||| IN
the  ||| S:1143 E:1147 ||| DT
MENA  ||| S:1147 E:1152 ||| NNP
region ||| S:1152 E:1158 ||| NN
,  ||| S:1158 E:1160 ||| ,
relating  ||| S:1160 E:1169 ||| VBG
to  ||| S:1169 E:1172 ||| TO
1 ||| S:1172 E:1173 ||| CD
)  ||| S:1173 E:1175 ||| -RRB-
short-course  ||| S:1175 E:1188 ||| JJ
preoperative  ||| S:1188 E:1201 ||| JJ
radiotherapy ||| S:1201 E:1213 ||| NN
,  ||| S:1213 E:1215 ||| ,
2 ||| S:1215 E:1216 ||| LS
)  ||| S:1216 E:1218 ||| -RRB-
dose  ||| S:1218 E:1223 ||| NN
of  ||| S:1223 E:1226 ||| IN
capecitabine ||| S:1226 E:1238 ||| NN
,  ||| S:1238 E:1240 ||| ,
3 ||| S:1240 E:1241 ||| LS
)  ||| S:1241 E:1243 ||| -RRB-
stereotactic  ||| S:1243 E:1256 ||| JJ
radiotherapy  ||| S:1256 E:1269 ||| NN
for  ||| S:1269 E:1273 ||| IN
liver  ||| S:1273 E:1279 ||| JJ
metastasis ||| S:1279 E:1289 ||| NN
,  ||| S:1289 E:1291 ||| ,
and  ||| S:1291 E:1295 ||| CC
4 ||| S:1295 E:1296 ||| LS
)  ||| S:1296 E:1298 ||| -RRB-
qualification  ||| S:1298 E:1312 ||| NN
of  ||| S:1312 E:1315 ||| IN
surgeons  ||| S:1315 E:1324 ||| NNS
performing  ||| S:1324 E:1335 ||| VBG
colorectal  ||| S:1335 E:1346 ||| JJ
surgery ||| S:1346 E:1353 ||| NN
.  ||| S:1353 E:1355 ||| .
The  ||| S:1355 E:1359 ||| DT
modification  ||| S:1359 E:1372 ||| NN
of  ||| S:1372 E:1375 ||| IN
NCCN  ||| S:1375 E:1380 ||| NNP
Colorectal  ||| S:1380 E:1391 ||| NNP
Cancer  ||| S:1391 E:1398 ||| NNP
Guidelines  ||| S:1398 E:1409 ||| NNP
for  ||| S:1409 E:1413 ||| IN
use  ||| S:1413 E:1417 ||| NN
in  ||| S:1417 E:1420 ||| IN
the  ||| S:1420 E:1424 ||| DT
MENA  ||| S:1424 E:1429 ||| NNP
region  ||| S:1429 E:1436 ||| NN
represents  ||| S:1436 E:1447 ||| VBZ
a  ||| S:1447 E:1449 ||| DT
step  ||| S:1449 E:1454 ||| NN
toward  ||| S:1454 E:1461 ||| IN
creating  ||| S:1461 E:1470 ||| VBG
a  ||| S:1470 E:1472 ||| DT
uniform  ||| S:1472 E:1480 ||| JJ
practice  ||| S:1480 E:1489 ||| NN
in  ||| S:1489 E:1492 ||| IN
the  ||| S:1492 E:1496 ||| DT
region  ||| S:1496 E:1503 ||| NN
based  ||| S:1503 E:1509 ||| VBN
on  ||| S:1509 E:1512 ||| IN
evidence  ||| S:1512 E:1521 ||| NN
and  ||| S:1521 E:1525 ||| CC
local  ||| S:1525 E:1531 ||| JJ
experience ||| S:1531 E:1541 ||| NN
.  ||| S:1541 E:1543 ||| .
